Publications
National Hospital Cost Data Collection (NHCDC) Public Sector Report 2013–14
The National Hospital Cost Data Collection (NHCDC) is a unique collection and valuable evidence base that is used across the Australian health system.
Mental Health Costing Study
The Mental Health Costing Study aims to produce a robust consumer level data set that is representative of mental health services provided in Australia.
Australian Refined Diagnosis Related Groups Version 6.x Addendum
The Independent Hospital Pricing Authority (IHPA) is committed to providing the Australian health care industry with a nationally consistent method of classifying all types of patients, their treatment and associated costs. Consequently, resources continue to be devoted...
Australian Refined Diagnosis Related Groups (AR-DRG) v7.0 (short and long description)
This resource shows the Australian Refined Diagnosis Related Groups (AR-DRG) v7.0 (short and long description).
Admitted Hospital Care Types
This guide is intended to provide assistance when assigning care types, especially for those patients that may potentially have care that applies to more than one care type.
National Hospital Cost Data Collection, Data Set Specifications, Round 16 (Financial year 2011-12)
IHPA is responsible for determining relevant data set specifications to enable Activity Based Funding. These specifications have been developed in collaboration with IHPA’s committees and working groups.
Activity based funding (ABF) - Data Collection Compliance Reports 2015 – 2020
The Independent Hospital Pricing Authority (IHPA) publishes Data Compliance Reports including a Quarterly Report, as required by the National Health Reform Agreement (B 102).
Activity based funding (ABF) - Data Collection Compliance Reports 2009 – 2014
This resource contains quarterly Activity based funding (ABF) - Data Collection Compliance Reports for the years 2009 through to 2014.
Culturally and Linguistically Diverse (CALD) Patient Costing Study Report
The purpose of this costing study was to undertake an analysis of CALD patients to inform a policy decision for whether an adjustment is warranted to the National Efficient Price for CALD patients.